Virtual Dialogue: Cancer patients are the primary victims of the... Date and time 16 November - 16 November Organiser(s): Union for International Cancer Control (UICC) Preview Text Antimicrobial resistance (AMR) is a public health issue that needs urgent attention at the global, national and health facility levels. Infections become drug-resistant when the pathogens that cause them adapt and change over time, developing the ability to resist the medicines designed to kill them. Read more about Virtual Dialogue: Cancer patients are the primary victims of the superbug crisis
EACR The Tumour Ecosystem: Cellular Interactions & Therapeutic... Date and time 19 March - 21 March Location The European Association for Cancer Research, held at Centro Congressi Giovanni XXIII Viale Papa Giovanni XXIII, 106 24121 Bergamo BG Italy Organiser(s): The European Association for Cancer Research Preview Text Learn about tumour microenvironment breakthroughs, e.g. the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs, and novel insights into tumour-host interactions including changes in metabolism, the nervous system, and response to therapy. Read more about EACR The Tumour Ecosystem: Cellular Interactions & Therapeutic Opprtunities
ATOM Coalition information session with Q&A (Asia) Date and time 21 September - 21 September Organiser(s): ATOM Coalition Preview Text This webinar for UICC members in ATOM Coalition target countries will provide a comprehensive look into the ATOM Coalition’s objectives, operational approach, target countries for the next five years and future implementation plans. Read more about ATOM Coalition information session with Q&A (Asia)
EACR Cancer Multiomics & Computational Biology Date and time 30 April - 02 May Location The European Association for Cancer Research; held at the Weizmann Institute for Science Weizmann Institute for Science Rehovot 76100 Israel Organiser(s): The European Association for Cancer Research Preview Text This new edition of our renowned Cancer Genomics series covers the latest developments in genomics and bioinformatics including machine learning/AI, single-cell/spatial analysis of cancers, cell plasticity, cancer immunity genomics, data integration/convergence, epigenetics, and genomic instability. Read more about EACR Cancer Multiomics & Computational Biology
ATOM Coalition information session with Q&A (Latin America / Africa /... Date and time 20 September - 20 September Organiser(s): ATOM Coalition Preview Text This webinar for UICC members in ATOM Coalition target countries will provide a comprehensive look into the ATOM Coalition’s objectives, operational approach, target countries for the next five years and future implementation plans. Read more about ATOM Coalition information session with Q&A (Latin America / Africa / Middle East & Europe)
Virtual Dialogue: Cartographie du rôle des organisations de la société... Date and time 26 September - 26 September Organiser(s): Union for International Cancer Control (UICC) Preview Text Des avancées récentes, telles que la recommandation d'une dose unique, ont donné un nouvel élan à l'amélioration de l'accès à la vaccination contre le papillomavirus et à son extension. Les OSC peuvent jouer un rôle essentiel dans la disponibilité, l'accès et la création de la demande pour atteindre l'objectif de 90 % de filles vaccinées. Read more about Virtual Dialogue: Cartographie du rôle des organisations de la société civile dans la vaccination contre le papillomavirus
Virtual Dialogue: Landscaping of CSO’s role in HPV vaccination Date and time 26 September - 26 September Organiser(s): Union for International Cancer Control (UICC) Preview Text Recent advances, such as the single-dose recommendation, as well as global commitments, have set a refreshed momentum for driving change in terms of access and scale-up of HPV vaccination. CSOs can play a critical role, particularly as advocates, for the availability, access and demand creation to reach the 90% target of girls vaccinated. Read more about Virtual Dialogue: Landscaping of CSO’s role in HPV vaccination